Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limited - PE Ratioverified

BXPHF

Price:

$0.02412

Market Cap:

$43.83M

Botanix Pharmaceuticals Limited, an Australian company established in Leederville in 1984, specializes in the research and development of novel dermatological and antimicrobial solutions. The company's core mission involves creating innovative treatments for a range of common skin conditions and infections. Its promising product pipeline includes: Sofpironium Bromide: An investigational medication for primary axillary hyperhidrosis, which has successfully completed Phase 3 clinical trials. BTX 1503: A transdermal gel formulation designed to treat severe acne in both adult and teenage patients, having concluded Phase II clinical studies. BTX 1801: This candidate has finished Phase IIb clinica...[Read more]

Industry

Biotechnology

IPO Date

2019-09-09

Stock Exchange

OTC

Ticker

BXPHF

The PE Ratio as of June 2026 (TTM) for Botanix Pharmaceuticals Limited (BXPHF) is -0.80

According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.80. This represents a change of -87.54% compared to the average of -6.42 of the last 4 quarters.

Botanix Pharmaceuticals Limited (BXPHF) Historical PE Ratio (quarterly & annually)

How has BXPHF PE Ratio performed in the past?

The mean historical PE Ratio of Botanix Pharmaceuticals Limited over the last ten years is -10.67. The current -0.80 PE Ratio has changed 649.62% with respect to the historical average. Over the past ten years (40 quarters), BXPHF's PE Ratio was at its highest in in the December 2020 quarter at 44.64. The PE Ratio was at its lowest in in the December 2009 quarter at -4471.15.

Quarterly (TTM)
Annual

Average

-10.67

Median

-5.85

Minimum

-34.24

Maximum

-2.18

Botanix Pharmaceuticals Limited (BXPHF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Botanix Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 979.94%

Maximum Annual PE Ratio = -2.18

Minimum Annual Increase = -82.06%

Minimum Annual PE Ratio = -34.24

Quarterly (TTM)
Annual
YearPE RatioChange
2025-6.84-80.03%
2024-34.24108.07%
2023-16.46289.74%
2022-4.22-82.06%
2021-23.53979.94%
2020-2.18-73.62%
2019-8.2669.68%
2018-4.8724.51%
2017-3.9175.91%
2016-2.22-3.70%

Botanix Pharmaceuticals Limited (BXPHF) Average PE Ratio

How has BXPHF PE Ratio performed in the past?

The current PE Ratio of Botanix Pharmaceuticals Limited (BXPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-19.18

5-year avg

-17.06

10-year avg

-10.67

Botanix Pharmaceuticals Limited (BXPHF) PE Ratio vs. Peers

How is BXPHF’s PE Ratio compared to its peers?

Botanix Pharmaceuticals Limited’s PE Ratio is greater than Innate Pharma S.A. (-2.92), less than NDT Pharmaceuticals Inc. (2.39K), greater than Molecular Partners AG (-1.98), greater than Scancell Holdings plc (-39.06), greater than Brii Biosciences Limited (-2.98), greater than JW (Cayman) Therapeutics Co. Ltd (-1.00), greater than Hofseth BioCare ASA (-3.79), greater than Ascend Wellness Holdings, Inc. (-0.82), greater than Kintor Pharmaceutical Limited (-4.41), greater than NervGen Pharma Corp. (-8.41),

Build a custom stock screener for Botanix Pharmaceuticals Limited (BXPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Botanix Pharmaceuticals Limited (BXPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Botanix Pharmaceuticals Limited's PE Ratio?

How is the PE Ratio calculated for Botanix Pharmaceuticals Limited (BXPHF)?

What is the highest PE Ratio for Botanix Pharmaceuticals Limited (BXPHF)?

What is the 3-year average PE Ratio for Botanix Pharmaceuticals Limited (BXPHF)?

What is the 5-year average PE Ratio for Botanix Pharmaceuticals Limited (BXPHF)?

How does the current PE Ratio for Botanix Pharmaceuticals Limited (BXPHF) compare to its historical average?